Stay updated on Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The old and new pages contain the same study record with unchanged core sections such as eligibility criteria, outcomes, locations, and contacts; any differences are limited to formatting and layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:04:52.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    - Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T05:30:36.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:03:48.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-14T19:12:21.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T15:19:35.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility and location details, as well as a revision to the content related to renal cell carcinoma and various blood proteins. Notably, the facility name and location in Vandœuvre-lès-Nancy, France, have been emphasized.
    Difference
    3%
    Check dated 2025-08-31T11:50:13.000Z thumbnail image

Stay in the know with updates to Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.